Customs seizure: difference between revisions
Diff·revision 5 → 6·16:25, 19 Dec 2024
Difference between revision 5 and revision 6 of Customs seizure. 4 lines changed; the page grew by 533 bytes.
| Revision 5 — 16:13, 8 Dec 2024 SeeAlsoSelma (talk) add the date the shortage listing ended 1,799 bytes ±0 | Revision 6 — 16:25, 19 Dec 2024 ShortageShona (talk) clarify that a business licence is not a manufacturing authorisation 2,332 bytes +533 | ||
|---|---|---|---|
| 10 | The distinction matters because seizure is frequently discussed as though it were a verdict on a supplier. It is a verdict on an importation, and the same material shipped to two jurisdictions may be released in one and refused in the other.{{r|fda_pip}} | 10 | The distinction matters because seizure is frequently discussed as though it were a verdict on a supplier. It is a verdict on an importation, and the same material shipped to two jurisdictions may be released in one and refused in the other.{{r|fda_pip}} |
| 11 | 11 | ||
| + | 12 | The legal position varies substantially between countries and, within federal systems, sometimes between sub-national units. This wiki describes the mechanism and does not give legal advice; see [[Regulatory status by jurisdiction]] and [[Personal importation policy]].{{r|wco}} | |
| + | 13 | ||
| 12 | == How a consignment is handled == | 14 | == How a consignment is handled == |
| 13 | Border authorities screen consignments against declared contents, origin, value and risk profile. A consignment may be released, held for further information, referred to a health or medicines regulator, or refused entry.{{r|wco}} | 15 | Border authorities screen consignments against declared contents, origin, value and risk profile. A consignment may be released, held for further information, referred to a health or medicines regulator, or refused entry.{{r|wco}} |
| 14 | 16 | ||
| 15 | Where a medicines regulator is involved, the question is generally whether the article is a medicine requiring authorisation in that jurisdiction, whether an exemption applies, and whether the quantity is consistent with the declared purpose. Research reagents and medicines are treated under different rules. | 17 | Where a medicines regulator is involved, the question is generally whether the article is a medicine requiring authorisation in that jurisdiction, whether an exemption applies, and whether the quantity is consistent with the declared purpose. Research reagents and medicines are treated under different rules. |
| + | 18 | ||
| + | 19 | Outcomes short of seizure are common and are what most consignments experience: a request for documentation, a delay, or a duty assessment. Seizure proper — forfeiture of the goods — is the most severe outcome and is not the only one.{{r|fda_pip}} | |
| 16 | 20 | ||
| 17 | == References == | 21 | == References == |